AU Patent

AU2017256172A1 — Modulators of cystic fibrosis transmembrane conductance regulator protein

Assigned to Galapagos NV · Expires 2018-09-06 · 8y expired

What this patent protects

The present invention provides for compounds of formula (I), wherein R

USPTO Abstract

The present invention provides for compounds of formula (I), wherein R

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: AU2017256172A1
Jurisdiction: AU
Classification: —
Expires: 2018-09-06
Drug substance claim: No
Drug product claim: No
Assignee: Galapagos NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.